ClinicalTrials.gov
public full text
Public Domain
Cost-Utility Analysis Hospital Versus Home in Multiple Myeloma
Bortezomib needs repetitive visits at hospital for injections. Hospital-at-Home (HaH) might be an attractive and suitable alternative in this situation. This study aim to perform a cost-utility analysis of two different strategies in several HaH structures within the Grand Est region in France.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy#807312
- Prospective Registration of mOrbidity and Mortality, individUal radioSensitivity and Radiation Technique (PROUST)#1137570
- CP-751,871 Treatment For Patients With Multiple Myeloma#837053
- Economic Evaluation of Sarcoma Patients Management in France#885572
- Immune Profiling in Multiple Myeloma#668819
Record · ID 1030626
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive